Oral cancer features high rates of mortality and morbidity, and is in dire need for new approaches. In the present study we analyzed 18 kDa translocator protein (TSPO) expression in oral (tongue) cancer tumors by immunohistochemistry. We also assayed TSPO binding in human tongue cancer cell lines and in the cellular fraction of saliva from tongue cancer patients, heavy cigarette smokers, and non-smoking healthy people as controls. Concurrently, TSPO protein levels, cell viability, mitochondrial membrane potential (Δψ m ), and general protein levels were analyzed. TSPO expression could be significantly enhanced in oral cancer tumors, compared to unaffected adjacent tissue. We also found that five-year survival probability dropped from 65% in patients with TSPO negative tumors to 7% in patients with highly expressed TSPO (p < 0.001). TSPO binding capacity was also pronounced in the human oral cancer cell lines SCC-25 and SCC-15 (3133 ± 643 fmol/mg protein and 6956 ± 549 fmol/mg protein, respectively). Binding decreased by 56% and 72%, in the SCC-25 and SCC-15 cell lines, respectively (p < 0.05) following CS exposure in cell culture. In the cellular fraction of saliva of heavy smokers TSPO binding was lower than in non-smokers (by 53%, p < 0.05). Also the cellular fraction of saliva exposed to CS in vitro showed decreased TSPO binding compared to unexposed saliva (by 30%, p < 0.001). Interestingly, oral cancer patients also displayed significantly lower TSPO binding in the cellular fraction of saliva compared to healthy controls (by 40%, p < 0.01). Our results suggest that low TSPO binding found in the cellular fraction of saliva may depend on genetic background as well as result from exposure to CS. We suggest that this may be related to a predisposition for occurrence of oral cancer.
Introduction
Oral cancer, which is induced primarily by cigarette smoke (CS), is the sixth most common malignancy. The carcinogenetic effect of cigarette smoke is enhanced by salivary modulation [1] . Oral cancer is characterized by a poor 5-year survival rate of only 50% and a high rate of morbidity, which have not changed significantly in the past half-century [2] [3] [4] ; thus, a better understanding of the biological nature of this aggressive disease is mandatory. Accordingly, we examined a potential novel player in the field of oral cancer, the translocator protein (18 kDa) (TSPO). The TSPO, which was previ-ously called peripheral-type benzodiazepine receptor (PBR), was first identified in 1977 as a diazepam binding site outside the brain [5] . This led to its assignment as 'peripheral-type' benzodiazepine receptor (PBR), to distinguish it from the central benzodiazepine receptor (CBR). While the CBR is primarily located on cell membranes of neurons in the CNS, the TSPO's location is mostly on mitochondrial membranes in various cell types. The TSPO has been detected in various densities in the majority of tissues tested [6, 7] . TSPO is located mainly in the outer mitochondrial membrane and is closely associated with the mitochondrial permeability transition pore (MPTP). Increased binding levels of TSPO have been observed in various human cancers [6, [8] [9] [10] [11] [12] [13] . The expression and binding levels of TSPO have been found to correlate with the tumorigenicity of various cancer cell lines [14] . Weisinger et al. [15] induced TSPO underexpression by using the stable anti-sense knockout approach in the MA-10 Leydig cell line. The resultant clones demonstrated increased tumorigenicity, using both in vitro (loss of contact inhibition and growth in soft agar) and in vivo (increased mortality after back grafting into isogenic mice) assays. Other studies applying TSPO knockdown by genetic 
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Biochimica et Biophysica Acta j o u r n a l h o m e p a g e : w w w. e l s e v i e r. c o m / l o c a t e / b b a d i s manipulation by various methods to various types of cancer cells, as well as application of TSPO specific ligands, showed that the TSPO plays an important role in the induction of all the aspects of the mitochondrial apoptosis pathway, as well as necrosis [16] [17] [18] [19] [20] .
In the current study we used 3 models to study the potential pathogenic role of TSPO in oral cancer. These models included oral cancer tissues, oral cancer cell lines, and the cellular fraction of saliva of oral cancer patients. The salivary analysis was also conducted in non-smoking healthy individuals as well as in heavy smokers, both in vivo and in vitro.
Patients and methods

Experimental design
The in vivo part of the study was based on an analysis of 69 patients (33 males and 36 females aged 65.7 ± 15.2 years) with tongue cancer whose archival paraffin-embedded pathological material was available for immunohistochemical staining analysis of TSPO. In 41 cases we studied the TSPO staining levels together with those of Skp2 and p27 proteins. The analysis was performed as previously described [21] . Seventeen patients were diagnosed with stage 1 disease; 27 with stage 2; 10 with stage 3; and 15 with stage 4. All patients had their tumors resected within 1-2 weeks after diagnosis, followed by radiation therapy to the head and neck region for patients at stages 2-4, with a mean dose of 60 Gy. The study protocol was approved by the Institutional Review Board. Clinical data included histopathological grading, tumor-node-metastasis (TNM) staging, and status at the end of the study (alive or deceased).
In the in vitro part of the study we analyzed the TSPO binding and expression in the oral cancer cell lines, SCC-25 and SCC-15, purchased from the American Type Culture Collection (ATCC, Manassas, VA, USA). In addition, the cellular fraction of saliva from oral cancer patients was analyzed, as well as from a group of cigarette smokers, and their control groups matching in age and gender. For the oral cancer patient's analysis, whole saliva was collected from a group of otherwise-healthy, consenting oral cancer patients who were compared to a control group of healthy individuals who matched in age and gender. None of the patients had a history of smoking, none of alcohol-drinking, and none had a history of oral pre-malignant lesions or any other oral disease. All cancer lesions were located at the lateral aspect of the mobile tongue. A similar approach was applied previously to groups of oral cancer patients whose rate of smoking habits was very low [22] . The saliva was collected prior to the administration of the therapy, and frozen at − 70°C before further processing and analysis.
For in vivo salivary analysis of a group of heavy smokers (over 20 cigarettes daily for at least 10 years) all smokers were asked to schedule the smoking of one of their cigarettes immediately prior to saliva collection, to reduce potential variability that may otherwise be introduced by the various time spans between exposure to cigarette smoke and saliva collections, as previously described [23] . The smokers were compared with a control group of healthy non-smoking individuals. Following collection and storage, the salivary samples were subjected to cell viability observations, TSPO binding assays, Western blot analysis, and protein level determination as previously described [24] [25] [26] [27] . It has been reported previously that saliva may contain various types of cells, including exfoliated epithelial mucosal cells, [22, [28] [29] [30] . We also conducted an in vitro salivary analysis in which the cellular fractions of saliva samples collected from healthy non-smoking volunteers (age range 20-65 years; 60% females and 40% males) were subjected to TSPO binding assay following exposure to cigarette smoke (14 mg tar and 0.9 mg nicotine per cigarette), as previously described [1] . Briefly, a cigarette was combined with a vacuum system to enable the inhalation of gas-phase cigarette smoke into a sealed apparatus containing the salivary samples (whole saliva) [1] . Previous studies have shown, by measuring the NO 2 -concentrations in the media, that the time of exposure to the smoke correlates directly with the level of exposure to cigarette smoke [31] [32] [33] . Using the same system we also exposed oral cancer cell lines to cigarette smoke. Using these various models allowed studying oral cancer both at the tissue level (specimens of tumors) and at the cellular level (cells in saliva and oral cancer cell lines in cell culture medium).
Immunohistochemical analysis and Western blot
The preparation and specificity of the antiserum against TSPO were described previously [17, 18, 20] . This antiserum was used for the immunohistochemistry and Western blot analysis of the present study. Western blot analysis with this antiserum was performed as described in detail previously [17, 18, 20] . Labeling of β-actin was used as a loading control. Labeling for the 32 kDa voltage dependent anion channel (VDAC) was done as routinely performed in our laboratory (e.g. [17, 20, 27] ) as it is a protein closely associated with the TSPO.
For immunohistochemical staining of oral cancer specimens and control tissue, five micron sections were deparaffinized with xylene and rehydrated in a series of ethanol. Endogenous peroxidase was blocked by 3% hydrogen peroxide in methanol for 20 min. For epitope retrieval, slides were heated in a microwave oven at 92°C for 20 min in a Tris-EDTA-buffer pH 8.0. After cooling, slides were washed in distilled water and then in phosphate-buffered saline (pH 7.4). Slides were incubated overnight at 4°C with the primary antiserum directed against TSPO diluted 1:100. Staining was completed with a Histostain-Plus kit (Zymed laboratories, CA). Color reaction product was developed with aminoethylcarbazole as the chromogen. All sections were counterstained with hematoxylin, dehydrated, and cover slipped. Incubations with phosphate-buffered saline containing 1% bovine serum albumin instead of the primary antibody were used as negative controls. Skp2 and p27 antisera were applied with similar immunostaining procedures, as described previously [21, 34] .
Staining intensity was examined microscopically, double blind, as neither the person examining the sections nor the person providing the sections to the examiner knew the patient origin of the samples. Weak cytoplasmic staining intensity for TSPO of tumor cells was graded <1 (weak). Weak staining meant that less than 50% of tumor cells were stained. Moderate to strong cytoplasmic staining of tumor cells was graded >1 (moderate-strong). In all cases of moderate to strong staining for TSPO more than 50% of tumor cells were stained. Skp2 and p27 staining intensity was determined as described previously i.e. at least 500 tumor cell nuclei were counted and from this population the percentage of Skp2 and p27 positive cells was calculated [21, 34] .
Cell viability
Cell viability was determined in saliva samples using the Trypan Blue exclusion test. Following treatment, saliva samples were centrifuged at 800 × g for 10 min and the pellet containing the cellular fraction was suspended in phosphate-buffered saline (PBS). Cell counting was performed using an inverted microscope and a hemocytometer. Both viable and non-viable cells were counted and the percentage of viable cells was calculated from the total number of cells.
Mitochondrial transmembrane potential analysis
The specific stain JC-1 (5,5′,6,6′-tetrachloro-1,1′,3,3′-tetraethylbenzimidazolylcarbocyanine iodide) was used to assay changes in the Δψ m following exposure oral cancer cell lines to cigarette smoke, as described in detail previously [17, 20, 35] . Briefly, samples of confluent cells were collected and centrifuged at 1200 × g for 10 min. Cell pellets were re-suspended in 1 µg/ml JC-1 solution in PBS and incubated at 37°C for 30 min in the dark. After incubation, the cells were centrifuged at 1200 × g for 10 min, and re-suspended in 0.5 ml PBS. Then, the cell suspensions were transferred into 5 ml FALCON ® FACS tubes and analyzed with the flow cytometer using CellQuest software.
TSPO binding analysis of saliva and oral cancer cells
Assays of [ 3 H] PK 11195 binding to membranes of the SCC-15 and SCC-25 cells for Scatchard analysis were conducted, according to methods described previously [14, 16, 25] . The reaction mixture contained 400 µl of the homogenized samples and 25 µl of [ 3 H]PK 11195 (final concentration of 0.2-6 nM), in the absence (total binding) or in the presence (non-specific binding) of 10 µM unlabeled PK 11195. After 80 min incubation at 4°C, the samples were filtered through Whatman CF/C filters using a vacuum system, washed three times with 4 ml of 5 mM ice cold phosphate buffer and placed in vials containing 4 ml of CytoScint™ (MP Biomedicals, Costa Mesa, CA). Radioactivity was counted after 12 h with a liquid scintillation analyzer. Specific binding was obtained by subtracting non-specific binding from total binding. The maximal binding capacity (B max ) and equilibrium dissociation constant (K d ), were calculated from the saturation curve of [ 3 H]PK 11195 binding, using Scatchard analysis.
For binding analysis of the cellular fraction of saliva, saliva samples were thawed and immediately centrifuged (800 ×g, 10 min, 4°C). The pellet, containing cells present in the saliva, was suspended in ice cold PBS, and then homogenized using a Kinematika Polytron (Luzerne, Switzerland) (setting 6) for 10 s. Total protein amount was determined, according to Bradford et al. [24] . TSPO binding assays of the saliva were conducted at concentrations of 6 nM and 12 nM of [ 3 H] PK 11195.
Statistical analysis
For categorical variables, frequencies and percentages were calculated. Distributions for categorical variables were compared and analyzed by the Fisher-Irwin exact test (small sample). For continuous variables, ranges, means, standard deviation, and standard error were calculated. The results of continuous variables between subgroups of patients were compared and analyzed by one way analysis of variance. The "Kaplan Meier estimate" was used to calculate the probability of survival rates as a function of time. The "Log Rank test" was used to compare between survival curves. p < 0.05 was taken as indicating statistically significant differences.
Results
TSPO levels in tongue cancer samples and clinical characteristics
Of the 69 oral cancer patients analyzed, oral tumor tissue of 12 patients (18%) stained negatively (=0) for TSPO while the other 57 patients (82%) the oral tumor tissue stained positively. The TSPO positive group was further categorized according to the intensity of staining: weak staining (<1) was found in 52% (36/69) of the specimens and moderate to strong staining (>1) in 30% (21/69). The TSPO staining was cytoplasmatic and slightly granular in the tumor tissue ( Fig. 1) , while the adjacent, normal-looking tissue was not stained by the anti-TSPO antibody (not shown), thus serving as internal controls. TSPO immunostaining was not significantly different between males and females nor was it significantly affected by age. Neither did the TSPO level significantly correlate with the grading (Fig. 1) nor with the T, N or M values.
Prognostic value of TSPO for oral cancer
In order to determine the prognostic value of TSPO for tongue cancer patients, we analyzed their cumulative survival according to TSPO expression levels. The intensity of TSPO staining correlated strongly with patient mortality. While 65% of the patients negative for TSPO and 57% of the patients with low (<1) TSPO levels in the tongue tumor were still alive at 60 months, only 7% of the patients with moderate to strong (>1) TSPO labeling of the tongue tumor tissue survived the 60 month period (p < 0.001) (Fig. 2) .
Correlations between TSPO, Skp2 and p27 expression levels in oral cancer tissue
Oral tumor TSPO staining levels correlated negatively with Skp2 levels and positively with p27. In particular, the mean Skp2 staining level of the TSPO positive (>0) specimens was significantly lower than that of the TSPO negative specimens (=0), 14.5 ± 2.1% (in 32 patients) vs. 21.5 ± 4.7% (in 7 patients), respectively (p = 0.05) (Table 1A) . In contrast, the mean p27 staining level of the TSPO positive specimens was significantly higher than that of the TSPO negative specimens, 39 ± 2.3% (in 34 patients) vs. 27 ± 4.2% (in 7 patients), respectively (p < 0.05), (Table 1B) .
TSPO in the SCC-25 and SCC-15 cells
We applied Western blot to determine whether TSPO is present in SCC-25 and SCC-15 cells. TSPO indeed are expressed in these human oral cancer cells. A representative Western blot of SCC-25 cells is presented in Fig. 3 . 
TSPO binding characteristics of [ 3 H]PK 11195 in the SCC-25 and SCC-15 oral cancer cell lines
Binding assays with [ 3 H]PK 11195 showed B max and K d values for the SCC-25 cells of 3133 ± 643 fmol/mg protein and 5.7 ± 2.0 nM, respectively (mean ± SD, n = 7). The B max and K d values of the SCC-15 cells were 6956 ± 549 fmol/mg protein and 5.9 ± 4.6 nM, respectively (mean ± SD, n = 16). Non-specific binding of [ 3 H]PK 11195 to human oral cancer cells was one third of the total binding. Representative Scatchard analysis of saturation curves of [ 3 H]PK 11195 specific binding to TSPO in human oral cancer cell lines SCC-25 and SCC-15 is presented in Fig. 4 .
TSPO binding and protein concentration following exposure of SCC-25 and SCC-15 cells to cigarette smoke
With binding assays of SCC-25 cells that were exposed to CS for 90 min, using [ 3 H]PK 11195 as a radioligand (final concentrations 3 nM and 6 nM) we found a significant decrease of 72% in TSPO binding at the concentration of 3 nM [ 3 H]PK 11195 in the CS-exposed cells, as compared to controls (n = 6; p = 0.01; data not shown). Similarly, the mean TSPO binding at a final concentration of 6 nM was lower by 56% in the CS-exposed cells (n = 6; p = 0.05; data not shown). Using a concentration of 3 nM [ 3 H]PK 11195 in CS-exposed SCC-15 cells, we also found a significant decrease of 64% in TSPO binding as compared to controls (data not shown). Total protein concentrations in SCC-25 and SCC-15 cells exposed to cigarette smoke (CS) for 90 min did not differ from controls, as measured by the method of Bradford et al. [24] .
Collapse of the mitochondrial transmembrane potential in SCC-25 cells exposed to cigarette smoke
The mitochondrial potential stability assays as assayed in SCC-25 cells showed that cigarette smoke caused collapse of the mitochondrial membrane potential (Δψ m ) in 80% of the cells, which present a significant increase from to control (Fig. 5 ). Collapse of the Δψ m can lead to cell death, including apoptosis [17, 20] . Cumulative survival rate and TSPO expression ('0' vs. '<1' vs. '>1') (n = 69). The probability of survival of patients with TSPO level (= 0) at 60 months was 65% while the probability of survival of patients with TSPO level (> 1) at 60 months was 7% only. ***p < 0.001 for > 1 vs. =0.
Table 1
The percentage of Skp2 labeled cells is significantly lower in tongue cancer specimens with enhanced TSPO levels (A), while the percentage of p27 levels is significantly higher in tongue cancer specimens with enhanced TSPO levels (B 
TSPO binding, cell viability, and total protein in the cellular fraction of saliva of heavy smokers
Similar to the effects of CS on the TSPO binding in the oral cancer cell lines, the cellular fraction of saliva from heavy smokers showed that the mean ± SE TSPO binding with the [ 3 H]PK 11195 ligand (at a final concentration of 6 nM) was reduced significantly by 53% (9 smokers), as compared to the control group (16 non-smokers) (p < 0.05) (Fig. 6A ). Western blot analyses of TSPO, VDAC and β actin proteins in the cellular fraction of saliva from non-smoking individuals and smoking individuals, revealed a lower expression of the TSPO and VDAC proteins in heavy smokers (Fig. 6B) . The mean ± SE percentage values of viable salivary cells were found to be similar in both groups, with 36 ± 4% in control saliva (16 non-smokers) and 37 ± 4% in smokers saliva (6 smokers). Also the mean ± SE of total protein concentration in saliva of non-smoking controls (16 non-smokers) and heavy smokers (9 smokers) were similar, i.e. 0.31 ± 0.08 mg/ml and 0.44 ± 0.16 mg/ml respectively.
3.9. In vitro analysis of TSPO binding, cell viability, and total protein levels in saliva exposed to CS Saliva samples which had been collected from healthy nonsmoking volunteers were exposed to CS in vitro and then the cellular fraction subjected to TSPO binding analysis. The binding analysis with a single [ 3 H]PK 11195 (6 nM final concentration), in control and CSexposed saliva revealed a significant 30% reduction of the TSPO binding (n = 34, p < 0.001) in response to CS exposure, compared to sham controls (Fig. 7) . Cigarette smoke did not appear to affect cell viability in saliva. The mean percentage values of viable cells were found to be similar in both groups, with 32.0 ± 3.8% in control saliva (n = 25) and 36.0 ± 3.5% (n = 25) in cigarette smoke-exposed saliva. The mean total protein concentrations in the cellular fractions from the control and the cigarette smoke-exposed samples were similar (data not shown).
TSPO binding, cell viability, and total protein levels in saliva of oral cancer patients
We conducted two separate binding experiments on saliva samples of oral cancer patients and healthy controls, using [ 3 H]PK 11195 as a radioligand. In the first experiment we used two concentrations of [ 3 H]PK 11195 (6 nM and 12 nM), and in the second experiment we used 6 nM only. In the first experiment ( Fig. 8) we compared 13 salivary samples of oral cancer patients with 6 salivary samples of controls, and found a significant 38% decrease in TSPO binding at the concentration of 6 nM [ 3 H]PK 11195 (p < 0.05) in the cellular fraction of saliva from oral cancer patients, as compared to controls. Similarly, the mean TSPO binding at a final concentration of 12 nM was significantly lower by 41% in the cancer patients (p < 0.05) (Fig. 8 ). In the second experiment, using 6 nM final concentration of [ 3 H]PK 11195, the decrease in TSPO binding in the cellular fraction from saliva of oral cancer patients was 40% (n = 12 for healthy controls, n = 7 for oral cancer patients, p < 0.05).
Viability assays with Trypan blue showed that the mean ± SE percentage values of viable cells were similar in both groups, with 48 ± 7% in saliva of controls (n = 16) and 40 ± 4% in saliva of oral cancer patients (n = 7). Also the mean ± SE total protein concentration [24] in the cellular fraction of saliva from healthy controls (n = 35) and oral cancer patients (n = 9) were similar (0.32 ± 0.05 mg/ml and 0.35 ± 0.08 mg/ml, respectively).
Discussion
To our knowledge this is the first study describing a conspicuous correlation between enhanced TSPO expression in oral cancer tissue and reduced patient survival rate. We also found statistically significant correlations between TSPO protein levels and those of Skp2 and p27. Levels of Skp2 and p27 were previously shown to correlate with the histopathological grading of oral cancer [21, 34] . Interestingly, TSPO binding in the cellular fraction of saliva from oral cancer patients was lower than in healthy controls. We assume that TSPO binding in the cellular fraction of saliva relates primarily to exfoliated epithelial mucosal cells, as this is a constant process in the GI tract, and we found this to be predominant type of cell present in saliva [22, 23, [28] [29] [30] . In a separate study we found the morphology of the majority of the cells in the saliva to be of a stratified epithelial type (in press, [36] ). Thus, TSPO may present an additional marker for oral cancer prognosis in the clinical set-up, on the one hand by its histopathological expression evaluation in oral cancer patients, and on the other hand by assays of salivary TSPO binding of at risk persons.
The enhanced levels of TSPO in oral cancer tissue correlating with poor prognosis are in accord with previous studies where TSPO overexpression has been shown to correlate with tumorigenicity in various human malignancies such as for example brain, breast, colon, and prostate cancer [6, 8, 9, [11] [12] [13] [14] 37] . Experimental studies inducing down-regulation of TSPO in MA-10 Leydig tumor cells, using antisense TSPO knockdown techniques, resulted in increased tumorigenicity in vitro and in vivo [15] , and TSPO knockdown in C6 glioma cells resulted in a 60% reduction of apoptotic rates [16] . Also other studies applying TSPO knockdown with other techniques to other cancer cell lines showed reduced apoptotic rates with reduced TSPO levels [18, 20] . Similar effects were obtained with application of the specific TSPO ligands PK 11195 and Ro5 4864 [14, 17, 19, 20] . Thus, these studies in various cancer cell lines, employing various methods of TSPO knockdown, and various types of TSPO ligands indicate that the TSPO can serve to activate the mitochondrial apoptosis cascade. In addition, it was found that the mechanism whereby TSPO initiates the mitochondrial apoptosis cascade includes oxidation of cardiolipins i.e. ROS generation at mitochondrial levels [19, 20] . Recently, it was found that activation of the TSPO affects the activity of the F o subunit of the mitochondrial ATPsynthase, i.e. TSPO can modulate the activity of this F o proton pump in the inner mitochondrial membrane [37] . We assume that this modulation of the F o proton pump presents the mechanism allowing TSPO to generate ROS for the induction of cardiolipin oxidation leading to activation of the mitochondrial apoptosis cascade [19, 38] . From these studies it was hypothesized that enhanced TSPO levels present a mechanism directed to cause programmed cell death, a mechanism that apparently does not function to its full potential in established cancers [19, [37] [38] [39] .
In the light of TSPO established pro-apoptotic i.e. anti-carcinogenic properties, it may be considered puzzling that the over-expression of TSPO in the oral cancer cases was correlated with reduced survival in the present study [16] [17] [18] [19] 39] . It has been postulated that mechanisms related to the TSPO are defective and thereby prevent TSPO to fully exert its pro-apoptotic function (i.e. either mechanisms serving to activate TSPO may be defective, or mechanisms typically activated by TSPO are defective). For example, caspase activation in C6 cells appears to be not fully functional [16] . An alternative explanation postulated here for the present data might be that the over-expressed TSPO itself in the oral cancer tumors may be of a defective and malfunctioning nature. A similar mechanistic explanation is often given for the well known enhanced expression of mutated p53 which is demonstrated in most human cancers [40] . More studies regarding actual interactions between causes and progression of oral cancer, TSPO functions, and apoptosis are needed. It is also well recognized that careful consideration of parameters and paradigms is needed to come to generally applicable conclusions regarding the involvement of TSPO cancer cell proliferation and cell death [18, 20, [41] [42] [43] [44] . It was found in one study, for example, that both low concentrations and high concentrations of CoCl 2 lead to cell death of brain cancer cells, however, low concentrations CoCl 2 led to reductions in TSPO levels, while high concentrations of CoCl 2 enhanced TSPO levels [20] . Only application of TSPO knockdown showed that TSPO was required for apoptosis in this paradigm [20] . Furthermore, while the apoptosis can be considered an important feature of carcinogenesis, it is also well known that the TSPO is involved in other important functions, such as cholesterol transport over the outer mitochondrial membrane and modulation of steroidogenesis, inflammation, and immune response [39, 45] .
Analysis of TSPO in the oral cancer cell lines, SCC-25 and SCC-15, revealed that TSPO is well expressed in these cells. The oral cancer cell lines were sensitive regarding viability when exposed to cigarette smoke, in correlations with reductions in TSPO binding. For example, we found that cigarette smoke causes collapse of the mitochondrial membrane potential in SCC-25 cells. Regarding cells in saliva, exposure of salivary samples to cigarette smoke did not appear to affect viability of cells in these salivary samples, while simultaneously reductions in TSPO binding were observed. Similarly, oral cancer patients showed relatively low levels of TSPO in the cellular fraction of salivary samples, without concomitant effects on cell viability in these salivary samples. It is not clear why viability of cells in saliva is not affected by cigarette smoke, while cultured oral cancer cell lines appear to be very sensitive to cigarette smoke. More detailed studies are required to resolve these questions.
Our study may be giving an additional lead why cigarette smoke presents a main inducer of oral cancer as well as lung cancer and various other cancers [46] . We report here significantly reduced TSPO binding to membrane homogenates prepared from the cellular fraction of saliva from heavy smokers. Similarly, we found significantly reduced TSPO binding to membrane homogenates prepared from the cellular fraction of saliva of non-smoking oral cancer patients. One possibility is that low levels of TSPO protein expression and/or binding, either due to exposure to cigarette smoke, or due to genetic disposition, as suggested by our salivary assays, renders cells more sensitive to induction of carcinogenesis ( Fig. 9 ). Previous studies, applying TSPO knockdown have shown that reduced TSPO levels (TSPO knockdown) can reduce apoptotic levels, this may prevent programmed cell death in neoplastic cells [16, 18, 20] . As we do not see effects of cell death in salivary samples of heavy smokers and oral cancer patients, at present we cannot conclude definitely which is the mechanism whereby reduced TSPO levels in the cellular fraction of saliva may potentially contribute to oral cancer tumorigenicity. Furthermore, our data presently do not resolve whether reduced TSPO binding in the cellular fraction of saliva from cigarette smokers is due to an acute effect of cigarette smoke exposure, or a long term effect due to the chronic cigarette smoke exposure. More studies are needed to answer these questions. Furthermore, the specific molecular biological mechanism by which cigarette smoke reduces TSPO binding, as currently shown in the SCC-25 and SCC-15 cells, and salivary cells, is yet to be elucidated. Previous studies have suggested that oxidative stress can affect the affinity of the TSPO due to the formation of homomeric TSPO multimers [47] , this may be part of the mechanism whereby cigarette smoke may affect TSPO binding.
A potential role of TSPO in the pathogenesis of oral cancer may originate from its location at chromosome 22q13.31. QRT-PCR has shown that specific region deletion on 22q13 is related to prognosis in oral cancer. Furthermore, the incidence of loss of heterozygosity (LOH) at chromosome 22q is high and is associated with the carcinogenesis of oral cancer [48, 49] . Different tumor suppressor genes related also to oral cancer are located in distinct regions on chromosome 22q [50] . Possibly, TSPO is part of this family of tumor suppressor genes.
In summary, our results indicate for the first time that increased TSPO levels in oral cancer tissue may be correlated with oral cancer mortality prognosis. On the other hand, reductions in TSPO binding in the cellular fraction of saliva in the oral cavity may contribute to the occurrence of cancer. This role of salivary TSPO may be based on induced reductions in the TSPO normal binding and/or protein expression rendered by inborn defects or by a later exposure to carcinogens such as those contained in cigarette smoke ( Fig. 9) . Thus, our studies suggest that TSPO malfunction may contribute to carcinogenesis, implying that the TSPO may be targeted as a venue for treatment of oral cancer. More studies correlating TSPO functions with oral cancer prognosis and diagnosis are needed. In particular, causal relationships need to be established in this area.
